Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

Related Articles by Review for PubMed (Select 23298486)

1.

Ethyl pyruvate administration suppresses growth and invasion of gallbladder cancer cells via downregulation of HMGB1-RAGE axis.

Li ML, Wang XF, Tan ZJ, Dong P, Gu J, Lu JH, Wu XS, Zhang L, Ding QC, Wu WG, Rao LH, Mu JS, Yang JH, Weng H, Ding Q, Zhang WJ, Chen L, Liu YB.

Int J Immunopathol Pharmacol. 2012 Oct-Dec;25(4):955-65.

PMID:
23298486
2.

An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies.

Musumeci D, Roviello GN, Montesarchio D.

Pharmacol Ther. 2014 Mar;141(3):347-57. doi: 10.1016/j.pharmthera.2013.11.001. Epub 2013 Nov 9. Review.

PMID:
24220159
3.

RAGE and RAGE ligands in cancer.

Logsdon CD, Fuentes MK, Huang EH, Arumugam T.

Curr Mol Med. 2007 Dec;7(8):777-89. Review.

PMID:
18331236
4.

Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).

van Beijnum JR, Buurman WA, Griffioen AW.

Angiogenesis. 2008;11(1):91-9. doi: 10.1007/s10456-008-9093-5. Epub 2008 Feb 9. Review.

PMID:
18264787
5.

Non-histone nuclear factor HMGB1 as a therapeutic target in colorectal cancer.

Ohmori H, Luo Y, Kuniyasu H.

Expert Opin Ther Targets. 2011 Feb;15(2):183-93. doi: 10.1517/14728222.2011.546785. Epub 2011 Jan 5. Review.

PMID:
21204727
6.

[HMGB1--its role in tumor progression and anticancer therapy].

Smolarczyk R, CichoĊ„ T, Jarosz M, Szala S.

Postepy Hig Med Dosw (Online). 2012 Nov 22;66:913-20. doi: 10.5604/17322693.1021108. Review. Polish.

7.

Critical role of RAGE in lung physiology and tumorigenesis: a potential target of therapeutic intervention?

Marinakis E, Bagkos G, Piperi C, Roussou P, Diamanti-Kandarakis E.

Clin Chem Lab Med. 2014 Feb;52(2):189-200. doi: 10.1515/cclm-2013-0578. Review.

PMID:
24108211
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk